Michael F. Cannon

Director of Health Policy Studies

Cato Institute

Michael F. Cannon

Director of Health Policy Studies

Cato Institute

Michael F. Cannon is the Cato Institute’s director of health policy studies. Cannon has been described as “an influential health-care wonk” (Washington Post), “ObamaCare’s single most relentless antagonist” ( New Republic), “ObamaCare’s fiercest critic” (The Week), and “the intellectual father” of King v. Burwell (Modern Healthcare). He has appeared on ABC, BBC, CBS, CNN, CNBC, C-SPAN, Fox News Channel, and NPR. His articles have been featured in the Wall Street Journal; the New York TimesUSA Today; the Washington Post; the Los Angeles Times; the New York Post; the Chicago Tribune; the Chicago Sun-Times; the San Francisco Chronicle;SCOTUSBlogHuffington PostForum for Health Economics and PolicyJAMA Internal MedicineHealth Matrix: Journal of Law-MedicineHarvard Health Policy Review; the Yale Journal of Health Policy, Law, and Ethics; and the Journal of Health Politics, Policy and Law. Cannon is the coeditor of Replacing Obamacare: The Cato Institute on Health Care Reform and coauthor of Healthy Competition: What’s Holding Back Health Care and How to Free It. Previously, he served as a domestic policy analyst for the U.S. Senate Republican Policy Committee, where he advised the Senate leadership on health, education, labor, welfare, and the Second Amendment.

He holds a BA in American government from the University of Virginia, and an MA in economics and a JM in law and economics from George Mason University. He is a member of the Board of Advisors of Harvard Health Policy Review.

A person listed as a contributor has spoken or otherwise participated in Regulatory Transparency Project events, publications, or multimedia presentations. A person's appearance on the website does not imply an endorsement or relationship between the person and the Regulatory Transparency Project. The Regulatory Transparency Project takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.

Contributions

Explainer Episode 45 – Telehealth & COVID-19

December 21, 2022

Health policy experts join us to discuss telehealth regulation – what it is, what happened to it during COVID-19, and what the opportunities and barriers are for future telehealth innovation.

Listen to this podcast

Explainer Episode 41 – Government Obstacles to Over The Counter Medicines

October 26, 2022

In this podcast, health policy experts discuss the role that the federal government plays in requiring prescriptions for medicines.

Listen to this podcast

Explainer Episode 39 – Tax Exclusions for Employer-Sponsored Health Insurance

September 12, 2022

In this episode, Michael F. Cannon explains why he views the federal income tax exclusion of employer-sponsored health insurance as an “accident of history.”

Listen to this podcast

Deep Dive Episode 209 – Who Should Decide Whether Drugs Are Available Over-The-Counter or by Prescription?

February 18, 2022

Michael Cannon, Joshua Sharfstein, and moderator Dan Troy debated who should decide which drugs require prescriptions.

Listen to this podcast

Who Should Decide Whether Drugs Are Available Over-The-Counter or by Prescription?

February 18, 2022

Michael Cannon, Joshua Sharfstein, and moderator Dan Troy debated who should decide which drugs require prescriptions.

Watch this video

Deep Dive Episode 133 – Medicare for All? A National Single-Payer v. Private Payer Insurance Debate

September 29, 2020

On September 22, the Federalist Society’s Villanova Student Chapter co-sponsored a debate on Medicare for All with the Villanova Law Health Law Society.

Listen to this podcast
Skip to content